We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bespak | LSE:BPK | London | Ordinary Share | GB0000946276 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 667.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:4725K Bespak PLC 01 April 2005 For immediate release 1 April 2005 Bespak plc Appointment of new Non-Executive Director Bespak plc (LSE: BPK), a leader in specialty medical devices, is pleased to announce the appointment of Adrian Auer as a Non-Executive Director of the Company with effect from 1 April 2005. Adrian joins Bespak from RMC Group plc (RMC), the UK supplier of construction materials, where he was Group Finance Director from 2002 until RMC's recent acquisition by Cemex S.A. de C.V. (Cemex). Previously Adrian was Group Finance Director of Taylor Woodrow plc, the house building and development company, and has held senior financial positions at companies that include ICI plc, BP plc and Admiral plc. Adrian is currently Chairman of Readymix plc, a company in which Cemex has retained a majority stake. There are no other details to be disclosed under paragraph 6.F.2. of the Listing Rules. John Robinson, Bespak's Chairman, commented: "I am delighted to welcome Adrian Auer to the Board. Adrian will assume Chairmanship of our Audit Committee in the next few months and his extensive financial and general industry experience will be of immense benefit to the Company." For further information please call: Bespak plc John Robinson - Chairman +44 (0) 20 7960 6320 Mark Throdahl - Chief Executive +44 (0) 20 1908 552 600 Martin Hopcroft - Group Finance Director Buchanan Communications +44 (0) 20 7466 5000 Tim Thompson / Mark Court / Mary-Jane Johnson Notes for Editors: About Bespak plc Bespak, a specialty medical devices company, is at the forefront of developing new delivery systems for the pharmaceutical industry. The company has a product range covering metered dose inhalers, dry powder devices, actuators and compliance aids. The company also develops and manufactures drug delivery devices for leading global pharmaceutical companies. The group, which has facilities in King's Lynn and Milton Keynes in the UK and in Cary, North Carolina, in the USA., is a public company quoted on the Official list of the London Stock Exchange (LSE: BPK). For more information, please visit www.bespak.com. This information is provided by RNS The company news service from the London Stock Exchange END BOAEAFLFEEASEFE
1 Year Bespak Chart |
1 Month Bespak Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions